Terns Pharmaceuticals (TERN) PT Raised to $36 at Barclays
Tweet
Share
E-mailGet Alerts TERN Hot Sheet
Price: $52.95 --0%
Rating Summary:
4 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
4 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
Barclays analyst Etzer Darout raised the price target on Terns Pharmaceuticals (NASDAQ: TERN) to $36.00 (from $28.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Morgan Stanley Upgrades DNB ASA (DNB:NO) (DNHBY) to Equalweight
- Barry Callebaut AG (BARN:SW) (BYCBF) PT Lowered to CHF1,230 at Morgan Stanley
- Vonocia SE (VNA:GR) (VNNVF) PT Lowered to EUR25 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
